Physician

Jessica R Bauman, M.D.

According to 2025 Medicare claims, Jessica Bauman, M.D. (NPI: 1619139235) practices hematopoietic cell transplantation and cellular therapy in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN, INC (NPI: 1417430166; TIN: 831002191) and primary practice location at 19111-2434.

Bauman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 112 traditional Medicare patients, billed 381 HCPCS/CPT codes, and received $34,730 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 462 prescription claims across 76 beneficiaries totaling $1,800,640 in drug costs, led by Lenvima (Lenvatinib Mesylate). DME data shows 35 claims. Open Payments data shows 60 records totaling $556,805. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $20,534 and ending at $34,730. Concurrently, Part D prescription costs have risen steadily, from $63,024 to $1,800,640. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	84	230	$20,534
2016	145	511	$42,707
2017	140	562	$40,759
2018	144	630	$47,030
2019	113	418	$31,117
2020	119	394	$28,199
2021	151	595	$52,026
2022	134	448	$38,604
2023	126	323	$29,588
2024	112	381	$34,730

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	37	245	$63,024
2016	75	601	$256,271
2017	75	382	$432,314
2018	82	434	$392,024
2019	83	397	$808,154
2020	71	387	$284,916
2021	98	505	$533,382
2022	86	518	$1,140,394
2023	69	379	$1,066,881
2024	76	462	$1,800,640

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	45	$3,728
2018	N/R	25	$2,514
2019	N/R	48	$4,519
2020	N/R	65	$7,325
2021	N/R	77	$14,912
2022	N/R	72	$7,798
2023	N/R	50	$5,225
2024	N/R	35	$3,490

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	15	15	$139
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	49	154	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	64	144	$76

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenvima	Lenvatinib Mesylate	24	780	$579,370
Vitrakvi	Larotrectinib Sulfate	13	390	$513,900
Retevmo	Selpercatinib	20	600	$279,034
Tagrisso	Osimertinib Mesylate	15	450	$256,004
Sorafenib	Sorafenib Tosylate	11	330	$39,510

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	21	$2,991
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	14	$499

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$3,945	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	57	$552,860	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jessica R. Bauman, M.D.?

Tedicare shows public-source Medicare data for Jessica R. Bauman, M.D. (NPI 1619139235), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jessica R. Bauman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jessica R. Bauman, M.D.?

Jessica R. Bauman, M.D. is linked to TEMPLE FACULTY PRACTICE PLAN, INC (billing NPI 1417430166) in the available physician profile data.

Does Jessica R. Bauman, M.D. have Open Payments data?

Jessica R. Bauman, M.D. has 60 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.